chr10-17603815-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_014241.4(HACD1):c.376-71G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.567 in 1,503,736 control chromosomes in the GnomAD database, including 244,929 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.61 ( 29263 hom., cov: 31)
Exomes 𝑓: 0.56 ( 215666 hom. )
Consequence
HACD1
NM_014241.4 intron
NM_014241.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.156
Genes affected
HACD1 (HGNC:9639): (3-hydroxyacyl-CoA dehydratase 1) The protein encoded by this gene contains a characteristic catalytic motif of the protein tyrosine phosphatases (PTPs) family. The PTP motif of this protein has the highly conserved arginine residue replaced by a proline residue; thus it may represent a distinct class of PTPs. Members of the PTP family are known to be signaling molecules that regulate a variety of cellular processes. This gene was preferentially expressed in both adult and fetal heart. A much lower expression level was detected in skeletal and smooth muscle tissues, and no expression was observed in other tissues. The tissue specific expression in the developing and adult heart suggests a role in regulating cardiac development and differentiation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 10-17603815-C-T is Benign according to our data. Variant chr10-17603815-C-T is described in ClinVar as [Benign]. Clinvar id is 1228253.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.747 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.614 AC: 93179AN: 151868Hom.: 29202 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
93179
AN:
151868
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.562 AC: 759724AN: 1351750Hom.: 215666 Cov.: 22 AF XY: 0.558 AC XY: 378101AN XY: 677310 show subpopulations
GnomAD4 exome
AF:
AC:
759724
AN:
1351750
Hom.:
Cov.:
22
AF XY:
AC XY:
378101
AN XY:
677310
Gnomad4 AFR exome
AF:
AC:
23219
AN:
30342
Gnomad4 AMR exome
AF:
AC:
25333
AN:
41592
Gnomad4 ASJ exome
AF:
AC:
14711
AN:
24972
Gnomad4 EAS exome
AF:
AC:
21248
AN:
39002
Gnomad4 SAS exome
AF:
AC:
37475
AN:
81634
Gnomad4 FIN exome
AF:
AC:
28581
AN:
53010
Gnomad4 NFE exome
AF:
AC:
573809
AN:
1019144
Gnomad4 Remaining exome
AF:
AC:
31938
AN:
56552
Heterozygous variant carriers
0
16787
33574
50362
67149
83936
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
15554
31108
46662
62216
77770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.614 AC: 93304AN: 151986Hom.: 29263 Cov.: 31 AF XY: 0.607 AC XY: 45110AN XY: 74258 show subpopulations
GnomAD4 genome
AF:
AC:
93304
AN:
151986
Hom.:
Cov.:
31
AF XY:
AC XY:
45110
AN XY:
74258
Gnomad4 AFR
AF:
AC:
0.754076
AN:
0.754076
Gnomad4 AMR
AF:
AC:
0.583847
AN:
0.583847
Gnomad4 ASJ
AF:
AC:
0.595677
AN:
0.595677
Gnomad4 EAS
AF:
AC:
0.518002
AN:
0.518002
Gnomad4 SAS
AF:
AC:
0.46531
AN:
0.46531
Gnomad4 FIN
AF:
AC:
0.537023
AN:
0.537023
Gnomad4 NFE
AF:
AC:
0.566419
AN:
0.566419
Gnomad4 OTH
AF:
AC:
0.616477
AN:
0.616477
Heterozygous variant carriers
0
1818
3637
5455
7274
9092
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
754
1508
2262
3016
3770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1790
AN:
3474
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at